| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.34 | 5e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.32 | 1e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.27 | 4e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.26 | 0.0005 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |